This year, Michael and Josh have gone to great lengths to bring you ASCO 2025. This year, we are doing things a bit differently, but rest assured, we are going to bring along with us a global host of experts to give you the very best out of the practice-changing, thought-provoking, design-defining trials that you know and love from this podcast.

This episode focuses on adjuvant atezolizumab in the colon cancer space and the use of perioperative durvalumab in the gastric cancer space. Both are highly interesting spaces, and both are potentially practice-changing

Don't forget to like and subscribe if you love what we do!

Studies discussed in the episode:

ATOMIC

MATTERHORN

For more episodes, resources and blog posts, visit www.inquisitiveonc.com

Please find us on Twitter @InquisitiveOnc!

If you want us to look at a specific trial or subject, email us at inquisitiveonc@gmail.com

Art courtesy of Taryn Silver

Music courtesy of AlisiaBeats: https://pixabay.com/users/alisiabeats-39461785/

Disclaimer: This podcast is for educational purposes only. If you are unwell, seek medical advice.

Oncology for the Inquisitive Mind is recorded with the support of education grants from our foundation partners Pfizer, Gilead Pharmaceuticals and Merck Pharmaceuticals. Our partners have access to the episode at the same time you do and have no editorial control over the content.

Hosted on Acast. See acast.com/privacy for more information.